ReNeuron logo
ReNeuron logo

Media coverage: Phase I trial in critical limb ischaemia

Pro-Active Investors : ReNeuron making good progress in clinical trials, says CFO

https://www.youtube.com/watch?v=gs_br8c1p2g

Section: News

  • News

Filter by:

  • Corporate
  • Product
    • Induced pluripotent stem cell (iPSC) Platform
    • CTX cells for Stroke Disability
    • CTX cells for Critical Limb Ischaemia
    • hRPCs for Retinitis Pigmentosa
    • CTX-derived Exosomes
  • Trial
    • Phase III clinical trial in stroke disability (PISCES-III)
    • Phase I clinical trial in stroke disability (PISCES)
    • Phase II clinical trial in stroke disability (PISCES-II)
    • Observational study in stroke
    • Phase I trial in critical limb ischaemia
    • Phase I/II clinical trial in retinitis pigmentosa

© ReNeuron Group plc 2025 All rights reserved

Website design by Carr Kamasa Design

  • Privacy Notice
  • Disclaimer